Proton Therapy Publication Proton Therapy Publication
Menu

Meta-analysis of the incidence and patterns of second neoplasms (SNs) after photon craniospinal irradiation (CSI) in children with medulloblastoma (MB).

April 2018
Executive summary

This meta-analysis reported that the 10-year cumulative incidence was 6.1% for all SNs, including 3.1% for SBNs (benign) and 3.7% for SMNs (malignant), with a majority in areas of exit RT dose.

Studies are needed to determine whether the use of proton therapy, which has no exit RT dose, is associated with a lower incidence of SNs.

Top cancer treatments
Pediatric
Brain and CNS

Other popular content

Proton Therapy Publication
Proton therapy publication
October 2021
Acute Hematological Outcomes after Proton and Photon Beam Craniospinal Irradiation in Pediatric Brain Tumors
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2021
Assessing concordance between patient-reported and investigator-reported CTCAE after PBT for prostate cancer.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2021
Bicentric Treatment Outcomes following PT for Non-Myxopapillary High-Grade Spinal Cord Ependymoma in Children
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2021
FLASH proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
August 2021
Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma
Link to the fully detailed content